A Francisella tularensis pathogenicity island required for intramacrophage growth

Journal of Bacteriology
Francis E NanoKaren L Elkins

Abstract

Francisella tularensis is a gram-negative, facultative intracellular pathogen that causes the highly infectious zoonotic disease tularemia. We have discovered a ca. 30-kb pathogenicity island of F. tularensis (FPI) that includes four large open reading frames (ORFs) of 2.5 to 3.9 kb and 13 ORFs of 1.5 kb or smaller. Previously, two small genes located near the center of the FPI were shown to be needed for intramacrophage growth. In this work we show that two of the large ORFs, located toward the ends of the FPI, are needed for virulence. Although most genes in the FPI encode proteins with amino acid sequences that are highly conserved between high- and low-virulence strains, one of the FPI genes is present in highly virulent type A F. tularensis, absent in moderately virulent type B F. tularensis, and altered in F. tularensis subsp. novicida, which is highly virulent for mice but avirulent for humans. The G+C content of a 17.7-kb stretch of the FPI is 26.6%, which is 6.6% below the average G+C content of the F. tularensis genome. This extremely low G+C content suggests that the DNA was imported from a microbe with a very low G+C-containing chromosome.

References

Dec 1, 1991·Journal of General Microbiology·L S AnthonyF E Nano
Sep 1, 1991·Infection and Immunity·L D AnthonyF E Nano
Apr 1, 1996·Molecular Microbiology·J E Galán
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Aug 14, 1998·Molecular Microbiology·G S Baron, F E Nano
Jun 21, 2001·JAMA : the Journal of the American Medical Association·D T DennisUNKNOWN Working Group on Civilian Biodefense
Feb 9, 2002·Current Opinion in Microbiology·Amal O Amer, Michele S Swanson
Oct 5, 2002·Clinical Microbiology Reviews·Jill EllisRichard W Titball
Oct 24, 2002·FEMS Microbiology Letters·Catherine G GrayFrancis E Nano
May 29, 2003·FEMS Microbiology Letters·Igor GolovliovVitaly Pavlov
Dec 19, 2003·FEMS Microbiology Letters·Crystal M LaurianoKarl E Klose
Mar 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Crystal M LaurianoKarl E Klose

❮ Previous
Next ❯

Citations

Jun 7, 2005·Biochimica Et Biophysica Acta·Richard L FeltsJohn J Tanner
Nov 16, 2013·Journal of Colloid and Interface Science·Archana MishraStanislaus Francis D'Souza
Jun 21, 2005·Protein Expression and Purification·Thomas J ReillyJohn J Tanner
Jan 11, 2005·Nature Genetics·Pär LarssonRichard W Titball
Nov 20, 2004·Nature Reviews. Microbiology·Petra C F OystonRichard W Titball
May 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jonathan W JonesDenise M Monack
Feb 10, 2006·The Journal of Biological Chemistry·Xiaoyuan WangChristian R H Raetz
Oct 19, 2005·The Journal of Experimental Medicine·Sanjeev MariathasanDenise M Monack
Dec 9, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Craig S RobbAlisdair B Boraston
Mar 4, 2008·Applied and Environmental Microbiology·Stephen A RodriguezKarl E Klose
Mar 7, 2006·Applied and Environmental Microbiology·Tamara M MaierD W Frank
Jul 25, 2006·Infection and Immunity·Eli B NixFrancis E Nano
Apr 23, 2008·Infection and Immunity·Robin R CravenThomas H Kawula
Mar 27, 2013·Infection and Immunity·Lydia M BarriganJeffrey A Frelinger
Jun 19, 2008·Infection and Immunity·Anna Brotcke, Denise M Monack
Aug 24, 2006·Infection and Immunity·Rebecca TempelFred Heffron
Sep 19, 2012·Infection and Immunity·Xhavit ZogajKarl E Klose
Oct 28, 2009·Infection and Immunity·Robert ChildJean Celli
Nov 5, 2008·Infection and Immunity·Aiping QinBarbara J Mann
Oct 25, 2006·Infection and Immunity·Nrusingh P MohapatraJohn S Gunn
Sep 27, 2006·Infection and Immunity·Anna BrotckeDenise M Monack
Feb 18, 2010·Infection and Immunity·Esteban SotoJohn P Hawke
Feb 19, 2009·Infection and Immunity·Karin L MeibomAlain Charbit
Apr 11, 2007·Infection and Immunity·Jingliang SuJing-Ren Zhang
Jun 23, 2006·Infection and Immunity·Kaiping DengEric J Hansen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.